Cell-free bioproduction of b-cryptoxanthin and zeaxanthin
US-2024368663-A1 · Nov 7, 2024 · US
US11274283B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11274283-B2 |
| Application number | US-202017029629-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 23, 2020 |
| Priority date | Dec 17, 2014 |
| Publication date | Mar 15, 2022 |
| Grant date | Mar 15, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method for the enzymatic conversion of a phenol substrate into a corresponding catechol product comprises the step of incubating the phenol substrate with a Ralstonia solanacearum tyrosinase enzyme, or a functional derivative thereof, in a reaction mixture, for a period of time sufficient to allow the enzyme convert at least some of the phenol substrate into the catechol product.
Opening claim text (preview).
What is claimed is: 1. A method for the enzymatic conversion of 4-halophenol into 4-halocatechol, the method comprising the step of incubating the 4-halophenol with a Ralstonia solanacearum tyrosinase enzyme or a functional derivative thereof, in a reaction mixture for a period of time sufficient to allow the Ralstonia solanacearum tyrosinase enzyme to convert at least 90% of the 4-halophenol into 4-halocatechol, in which the reaction mixture comprises ascorbic acid or its sodium salt, wherein the functional derivative is an engineered variant of Ralstonia solanacearum tyrosinase of SEQ ID NO: 1 selected from the group consisting of Y119F, V153A, D317Y and L330V (RV145); T183I, F185Y, N322S, and T359M (RVC10); and N322S (C10_N322S). 2. The method according to claim 1 in which the reaction mixture comprises at least 10 mM of the 4-halophenol. 3. The method according to claim 1 in which the reaction mixture comprises at least 20 mM ascorbic acid. 4. The method according to claim 1 in which the functional derivative of the Ralstonia solanacearum tyrosinase enzyme is capable of the 98% conversion of 10 mM 4-halophenol 4-halocatechol. 5. The method according to claim 1 in which the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof, is provided as an extract from a bacteria that expresses the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof. 6. The method according to claim 1 in which the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof, is provided as a bacteria that expresses the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof. 7. The method according to claim 1 in which the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof, is provided as a purified enzyme. 8. The method according to claim 1 in which the functional derivative of Ralstonia solanacearum tyrosinase enzyme is RV145. 9. The method according to claim 1 in which the functional derivative of Ralstonia solanacearum tyrosinase enzyme is RVC10. 10. The method according to claim 1 in which the functional derivative of Ralstonia solanacearum tyrosinase enzyme is C10_N322S. 11. The method according to claim 1 in which the Ralstonia solanacearum tyrosinase enzyme, or functional derivative thereof, is provided as a crude mixture in the form of a cell extract. 12. The method according to claim 1 in which the 4-halocatechol is separated from impurities present in the reaction mixture by chilling the reaction mixture after enzymatic conversion. 13. The method according to claim 1 in which the 4-halocatechol is separated from impurities present in the reaction mixture by refrigerating or freezing the reaction mixture after enzymatic conversion.
acting on paired donors with incorporation of molecular oxygen (1.14) · CPC title
Tyrosinase (1.14.18.1) · CPC title
aromatic · CPC title
involving oxidoreductase · CPC title
Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.